Leclanché Launches XN50, World’s First Li-ion Commercial Cell Featuring Echion Technologies’ XNO®
Source: EQS
Leclanché SA
/ Key word(s): Market Launch
Leclanché Launches XN50, World’s First Li-ion Commercial Cell Featuring Echion Technologies’ XNO®
YVERDON-LES-BAINS, Leclanché carried out stringent product development and verification to produce a cell that is ready for market adoption. Commercially available now, XN50 delivers the benefits expected from the new XNO® anode chemistry including 50% higher energy density vs. LTO technologies, fast charging and maintaining the highest cell safety and performance in extreme conditions. The XN50 cell can also deliver high power over an estimated cycle life of more than 10,000 cycles when used in heavy-duty applications, with studies showing less than 3% capacity loss and less than 15% resistance growth after 1,000 2C/2C charge/discharge cycles at 45°C. Leclanché’s unique water-based cathode formulation also ensures the XN50 cell electrodes are PFAS free, reducing its impact on the environment even further. Find out more about Leclanché’s leading high-quality energy storage solutions on https://www.leclanche.com/ and Echion’s XNO® battery materials at https://www.echiontech.com/. For more information, please contact communication@leclanche.com
# # #
About Leclanché Leclanché is a world leading provider of low-carbon footprint energy storage solutions based on lithium-ion cell technology. Established in 1909 in Yverdon-les-Bains, Echion is the world’s leading supplier of niobium-based active anode materials. Our product, XNO®, delivers lithium-ion battery performance highly suited for industrial applications that demand the highest productivity and lowest total cost of ownership. Powered by XNO® means lithium-ion batteries that can ultra-fast charge safely, maintain high energy densities even at low temperatures, and deliver high power across a cycle life of more than 10,000 cycles. Echion is headquartered in
Disclaimer This press release contains certain forward-looking statements relating to Leclanché's business, which can be identified by terminology such as "strategic", "proposes", "to introduce", "will", "planned", "expected", "commitment", "expects", "set", "preparing", "plans", "estimates", "aims", "would", "potential", "awaiting", "estimated", "proposal", or similar expressions, or by expressed or implied discussions regarding the ramp up of Leclanché's production capacity, potential applications for existing products, or regarding potential future revenues from any such products, or potential future sales or earnings of Leclanché or any of its business units. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of Leclanché regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Leclanché's products will achieve any particular revenue levels. Nor can there be any guarantee that Leclanché, or any of the business units, will achieve any particular financial results.
T: +49 (0) 711 947 670 E-mail: leclanche@sympra.de Investor Contact: T: +41 (0) 24 424 65 00 E-mail: invest.leclanche@leclanche.com
End of Media Release |
Language: | English |
Company: | Leclanché SA |
Av. des Sports 42 | |
1400 Yverdon-les-Bains | |
Phone: | +41 (24) 424 65-00 |
Fax: | +41 (24) 424 65-20 |
E-mail: | investors@leclanche.com |
Internet: | www.leclanche.com |
ISIN: | CH0110303119, CH0016271550 |
Valor: | A1CUUB, 812950 |
Listed: | |
EQS News ID: | 1992759 |
End of News |
|
1992759 23.09.2024 CET/CEST